EUVIMEDEUVIMED entdecken
Open Access

Identification of a novel missense mutation (L233Q) in the AMH gene in a polycystic ovary syndrome patient from Assam, India

Adity Paul, Surya Prakash Goud Ponnam, Sumita Gogoi Hazarika, Juri Khanikar

Menopausal Review · 2026 · 25 (1) · 10-18

DOI: 10.5114/pm.2026.161235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Menopausal Review, 2026. Verfasst von Adity Paul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biotechnology, School of Sciences, Tezpur University, Napaam, Sonitpur, Assam, India. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Polycystic ovary syndrome (PCOS) is a multifactorial, endocrinological, and reproductive condition among women of reproductive age worldwide, with a global prevalence between 6–13%. Multiple studies from different ethnicities have associated more than a dozen candidate genes with PCOS, including the anti-Mullerian hormone gene (AMH). To date, there have been no comprehensive reports on the molecular studies of PCOS patients from Assam, India. Material and methods The current study is a prospective, case-control, tri-centric, hospital-based study. We recruited 100 PCOS patients, diagnosed based on Rotterdam classification, and 50 controls. Relevant clinical data was recorded and tabulated. A candidate gene screening approach was employed to identify novel and reported sequence variations in the AMH gene.

Results

A novel pathogenic sequence variation, c.698T>A (homozygous), p.Leu233Gln substitution, was observed in a 31-year-old married female patient with no positive family history, with oligomenorrhea and multiple cysts in both ovaries. The observed sequence change variant was absent in 50 controls and was conserved across species. In silico tools such as SIFT, Polyphen2, Align GVGD, MutationTaster and I-Mutant2.0 had predicted the L233Q mutation to alter the structure and function of AMH protein.

Conclusions

This is the first study to report L233Q pathogenic missense mutation in the AMH gene in PCOS patient from India. Our finding adds to the spectrum of reported mutations in the AMH gene and provides further evidence on the importance of AMH in the aetiopathogenesis of PCOS and also might aid in developing novel diagnostic markers.

Schlagwörter

Stichwörter der Autor:innen

AMHIndiaPCOSRotterdam classificationmissense mutation

Autor:innen und Institutionen

  • Department of Molecular Biology and Biotechnology, School of Sciences, Tezpur University, Napaam, Sonitpur, Assam, India.
  • Dorika Hospital, Nikamul, Tezpur, Sonitpur, Assam, India.
  • Gogoi Nursing Home, Joymoti Pathar, Tezpur, Assam, India.
  • Matrikas IVF Centre, Hatigarh Chariali, Guwahati, Assam, India.

Zitieren

APA

Paul, A., Ponnam, S. P. G., Hazarika, S. G., & Khanikar, J. (2026). Identification of a novel missense mutation (L233Q) in the AMH gene in a polycystic ovary syndrome patient from Assam, India. Menopausal Review, 25(1), 10-18. https://doi.org/10.5114/pm.2026.161235

Vancouver

Paul A, Ponnam SPG, Hazarika SG, Khanikar J. Identification of a novel missense mutation (L233Q) in the AMH gene in a polycystic ovary syndrome patient from Assam, India. Menopausal Review. 2026;25(1):10-18. doi:10.5114/pm.2026.161235

BibTeX
@article{Paul2026,
  author = {Paul, Adity and Ponnam, Surya Prakash Goud and Hazarika, Sumita Gogoi and Khanikar, Juri},
  title = {Identification of a novel missense mutation (L233Q) in the AMH gene in a polycystic ovary syndrome patient from Assam, India},
  journal = {Menopausal Review},
  year = {2026},
  volume = {25},
  number = {1},
  pages = {10--18},
  doi = {10.5114/pm.2026.161235}
}
Kostenlos starten →